3 years ago

Daye raises £10 million to launch at-home vaginal microbiome testing platform and expand to the US

  • Daye, a London-based startup selling CBD-infused tampons and other period care products, has raised £10 million in Series A funding

  • The company plans to use the funding to launch its at-home vaginal microbiome testing platform and expand into the US market

  • The test, which is carried out with a tampon-based swab, allows users to access results online and book in-person or virtual appointments with specialists via the startup's app

  • Daye is also partnering with workplaces to provide its products as a perk to staff.

      • ProblemHealthcare

      "Many women experience vaginal infections and disruptions to their microbiome, leading to increased chances of UTIs, STIs, and fertility complications. Existing testing methods are often inconvenient, uncomfortable, and require a visit to a healthcare provider."

      Solution

      "Daye offers an at-home vaginal microbiome screening platform using a tampon-based swab for easy and comfortable testing. Users receive results online and can book in-person or virtual appointments with specialists via the app."

      Covered on